WESTFORD, Mass., Jan. 26,
2015 /PRNewswire/ -- Cynosure, Inc. (Nasdaq: CYNO), which
designs, manufactures and markets medical devices for aesthetic
procedures and precision surgical applications worldwide, today
announced that the Company will release its fourth-quarter 2014
financial results before the market opens on Tuesday, February 10 and host a conference call
for investors and analysts that day at 9:00
a.m. ET.
On the call, Chairman and Chief Executive Officer Michael Davin and President and Chief Financial
Officer Timothy Baker will discuss
Cynosure's financial results, as well as the Company's business
outlook and strategy.
Those who wish to listen to the conference call webcast should
visit the "Investors" section of the Company's website at
www.cynosure.com. The live call also can be accessed by
dialing (877) 709-8155 or (201) 689-8881. If you are unable
to listen to the live call, the webcast will be archived on the
Company's website.
About Cynosure, Inc.
Cynosure develops and markets
aesthetic treatment systems that enable plastic surgeons,
dermatologists and other medical practitioners to perform
non-invasive and minimally invasive procedures to remove hair,
treat vascular and benign pigmented lesions, remove multi-colored
tattoos, revitalize the skin, liquefy and remove unwanted fat
through laser lipolysis, reduce cellulite, clear nails infected by
toe fungus, ablate sweat glands and improve vaginal health.
Cynosure also markets radiofrequency energy sourced medical devices
for precision surgical applications such as facial plastic and
general surgery, gynecology, ear, nose, and throat procedures,
ophthalmology, oral and maxillofacial surgery, podiatry and
proctology. Cynosure's product portfolio is composed of a broad
range of energy sources including Alexandrite, diode, Nd: YAG,
picosecond, pulse dye, Q-switched lasers, intense pulsed light and
radiofrequency technology. Cynosure sells its products
globally under the Cynosure, Palomar, ConBio and Ellman brand names
through a direct sales force in the
United States, Canada,
Mexico, France, Germany, Spain, the United
Kingdom, Australia,
China, Japan and Korea, and through international
distributors in approximately 120 other countries. For
corporate or product information, visit Cynosure's website at
www.cynosure.com.
Contact
Scott
Solomon
Vice President
Sharon Merrill Associates
617-542-5300
cyno@investorrelations.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cynosure-to-host-fourth-quarter-2014-financial-results-conference-call-on-february-10-300025432.html
SOURCE Cynosure, Inc.